Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Bayer Nears Buy of Roche Unit

July 5, 2004 | A version of this story appeared in Volume 82, Issue 27

According to company insiders, Bayer is now in exclusive negotiations to acquire Roche's consumer health care unit. Some five other contenders, including several investment firms, have dropped out, they say. At the company's Innovation Day press forum last week, Bayer Chairman Werner Wenning refused to comment on the latest report, which predicts that Bayer will pay nearly $2 billion for the Roche unit. The Bayer staffers are optimistic that the deal will succeed and see a good fit between the Roche business and Bayer's own consumer health care products division.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.